Charles River Laboratories (CRL) Tops Q4 EPS by 10c, Guides FY17 EPS In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Charles River Labs (CRL) PT Raised to $84 at UBS Following Strong 4Q Results
February 15, 2017 9:31 AM ESTUBS analyst Jonathan Groberg maintains Sell rating and raises price target on Charles River Laboratories International (NYSE: CRL) to $84 (from $78), as the company announced revenue and EPS figures above consensus projections.
Groberg comments, "CRL reported 4Q16 results with reported revenue of $467m,... More
Charles River Labs (CRL) PT Raised to $104 at Jefferies Following Strong 4Q Results
February 15, 2017 8:11 AM ESTJefferies analyst David Windley reiterates Buy rating and raises price target on Charles River Laboratories (NYSE: CRL), as the company reported 2016 fourth quarter revenue and EPS above consensus.
Windley comments, "4Q results far outpaced consensus revenue/EPS driven by strength across the 3 segments.... More
